ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Prime Therapeutics

Official 2024 U.S. DOL Form 5500 summary for Prime Therapeutics (Prime Therapeutics LLC 401(k) Plan · EIN 26-0076803 · PN 001): $911.28M net assets, 7,237 active participants, and $8.18 per $10,000 (8.18 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorPrime Therapeutics
Filing IdentifierPrime Therapeutics LLC 401(k) Plan · EIN 26-0076803 · PN 001
Plan Category & State401(k) Defined Contribution (MN)
Asset-Size Peer Cohort$500M-$1B
Plan Net Assets (2024)$911.28M
Active Participants7,237
Direct Admin Fee Rate$8.18 per $10,000 (8.18 bps)
Cohort Peer Median$6.25 per $10,000 (6.25 bps)
Primary Recordkeeper / ProviderEdelman Financial Engines
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI